Mounjaro (tirzepatide) is a dual glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Before you blame your expanding waistline on your ...

Dr. Moawad is a neurologist and expert in brain health. She regularly writes and edits health content for medical books and publications. Supplements containing protein are recommended for people who ...

As black-market drugs go mainstream and legalization is within reach, entrepreneurs, investors and healthcare players are racing to cash in.

Eli Lilly on May 21 said its experimental weight-loss shot retatrutide delivered dramatic weight loss in a late-stage study of people with obesity. Lilly said people on the next-generation weight loss ...

Eli Lilly said its next-generation drug cleared a crucial late-stage trial in patients with obesity, delivering significant weight loss across doses. The results bring Lilly one step closer to filing ...

People who got the injection, retatrutide, lost 28 percent of their body weight on average after 80 weeks, Eli Lilly said. By Gina Kolata and Rebecca Robbins An experimental shot helped participants ...

As the weight-loss category grows more competitive, obesity-leader Eli Lilly LLY-1.21%decrease; down pointing triangle has started to look a bit richly valued to some investors. Prices for weight-loss ...

Ozempic, Mounjaro, and Zepbound can drive impressive weight loss, but stopping them is often followed by rapid weight regain. Researchers found that people regain weight faster after quitting these ...

For months, readers emailed Snopes and searched our website asking whether well-known public figures were really endorsing a gelatin — often specifically "pink gelatin" — trick for weight loss. The ...

Medicare has delayed a program for older Americans that would've required participating insurance companies to cover GLP-1 weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.